(Reuters) - Activist investor Bill Ackman's hedge fund has significantly increased its investment in Valeant Pharmaceuticals International , and signaled it may play a greater role in the beleaguered drugmaker’s strategy, according to a regulatory filing.
No comments:
Post a Comment